Demo data. These are fictitious sample companies used to preview GroWiser. The figures are not real and are not investment information.
Chambal Biotech Ltd
NSE: CHAMBALBIOBSE: 549886Pharma Formulations
₹603.25
▲ 13.05 (+2.21%)
Cash Flow
- FY22: 4,169
- FY23: 2,804
- FY24: 3,803
- FY25: 4,556
- FY26: 6,458
- FY22: -1,235
- FY23: -1,923
- FY24: -1,910
- FY25: -3,164
- FY26: -2,046
- FY22: -1,448
- FY23: -1,170
- FY24: 1,936
- FY25: -2,493
- FY26: 2,952
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operating activity | 4,169 | 2,804 | 3,803 | 4,556 | 6,458 |
| Capital expenditure | -1,235 | -1,923 | -1,910 | -3,164 | -2,046 |
| Cash from investing activity | -1,412 | -2,121 | -1,939 | -3,212 | -2,269 |
| Cash from financing activity | -4,205 | -1,854 | 71 | -3,837 | -1,236 |
| Net cash flow | -1,448 | -1,170 | 1,936 | -2,493 | 2,952 |
Figures in ₹ Cr unless marked per share (₹). Consolidated.
Showing 5 of 10 periods. Premium unlocks the full 10-year history. See Premium